Skip to content

Role of Positive Affect in Adjustment to HIV

CHAI Study: Coping, HIV, and Affect Interview Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00582023
Acronym
CHAI
Enrollment
160
Registered
2007-12-28
Start date
2004-09-30
Completion date
2012-06-30
Last updated
2013-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, coping, emotion, affect, HIV infection, Complimentary therapies

Brief summary

The purpose of this study is to examine the role of emotion and mood in the context of HIV.

Detailed description

A growing body of literature indicates that positive affect may have a unique adaptive role in the process of adjustment to chronic stress, independent of the effects of negative affects like depression. The overarching goal of this research is to provide evidence and direction for the development of interventions for people with HIV that include a focus on positive affect. To this end, this study will document the occurrence, predictors, and consequences of positive affect during the 18 months post-notification of HIV+ serostatus.

Interventions

None listed

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have been informed they were HIV positive within the past two months * Speak English * Be 18 years or older * Have the ability to provide informed consent to be a research participant

Exclusion criteria

* Severe cognitive impairment * Active psychosis

Design outcomes

Primary

MeasureTime frame
Well being18 month follow-up
Physical & Mental Health18 months
Coping Response18 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026